Kudos for September 2013



Mark Tyndall is helping with an application to have a supervised drug injection site in Ottawa. He was interviewed by Ottawa Citizen, CBC, and CTV News- ‘Ottawa groups applying for supervised drug injection site in the capital.’ He is quoted as saying: “We have very high rates of HIV in the city, very high overdose rates, a lot of people that are disconnected from any health services. This is exactly what the supervised injection site addresses.” There will be mock safe injection site at 216 Murray Street on September 30th.

Duncan Stewart in the news when his groundbreaking clinical trial, ENACT-AMI, announced treatment of the trial’s first patient. This the first time to use genetically enhanced stem cells to repair damaged heart muscle after a major heart attack. Details in Globe and Mail, Ottawa Citizen, CBC, CTV and Huffington Post.

Garth Nicholas led a study, published in New England Journal of Medicine. Dr. Nicholas’ team developed a new clinical risk calculator software that accurately classifies, 9 out of 10 times, which spots or lesions are benign and malignant on an initial lung CT scan among those at high risk for lung cancer. Findings will have immediate clinical impact worldwide. Details in NEJM. Reported by CBC.


Erin Keely and Clare Liddy have developed a virtual medical consultation tool that they hope can dramatically decrease wait times for specialty medical advice. Family physicians who submitted an electronic consultation obtained specialist’s advice on a patient in less than 3 days compared to typical wait times of several months for traditional in-person consultation. Article entitled: ‘Utilization, benefits, and impact of an e-Consultation Service across diverse specialties and primary care providers” and published in Telemed J.E. Health 2013 Aug 27th. [Epub ahead of print]

Marc Carrier, Phil Wells, Gregoire Le Gal, Marc Rodger, Esteban Gandara and Lana Castellucci published article in BMJ entitled: Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. Details in BMJ 2013;347:f5133.

Lynn Megeney awarded $545,000 from CIHR and $300,000 from Muscular Dystrophy Association to advance his research on caspases. Dr. Megeney has discovered that these proteins play a key role in tissue growth and regeneration. Details on MDA website and CIHR funded research database.


Dar Dowlatshahi has received a New Investigator Award of $300,000 from Heart & Stroke Foundation for “Predicting intracerebral hemorrhage expansion using the dynamic CT-angiography spot sign.”

Ride the Rideau was an incredible success with over 800 riders and raising a record $2,049,522 for cancer research. Phil Wells and team made the 2013 Top Fundraisers list with pledges of $29,000.

Shawn Marshall is lead author of a new set of guidelines published by the Ontario Neurotrauma Foundation which will aid family doctors in treatment and management of persistent post-concussion symptoms in adults. The guidelines are being published Tuesday (Sept 24th) for free at onf.org and concussionsontario.org.


Dave Conrad and team won honours at the 2nd annual startup Garage Pitch Competition where young entrepreneurs try to prove that their companies have the most promise. Their potential therapy, which uses small virus-derived particles to treat blood cancers, was judged to the Best Business Opportunity. Media attention in Nature’s Blood Cancer Journal, Ottawa Citizen, CTV, CBC and Huffington Post.